Advances in Compression Therapy for Venous and Lymphatic Disorders

Advances in Compression Therapy for Venous and Lymphatic Disorders

On-Demand Webcast

William Repicci
President and CEO
Lymphatic Education & Research Network
New York, New York

Stanley G. Rockson, MD
Co-Founder, Lymphatic Education & Research Network; Allan and Tina Neill Professor of Lymphatic Research And Medicine
Stanford University School of Medicine
Stanford, California

Emily Greenstein, ARPN, CNP, CWON, FACCWS
Nurse Practitioner
Sanford Health
Rasmussen College
West Fargo, North Dakota

Jeffrey D. Lehrman, DPM, FASPS, MAPWCA, CPC
Podiatrist / Consultant
A Step Ahead Foot & Ankle Center
Temple University School of Podiatric Medicine
Fort Collins, Colorado

Gwen McComy, RN, BSN
Wound Care Consultant
Milliken Healthcare
Spartanburg, South Carolina

Yvette Mier, BSN, RN, CWON
Outpatient Wound Treatment Center
Wellstar Kennestone Regional Medical Center
Marietta, Georgia

Lynn M. Peterson, RN, CWOCN, CLWT
Clinical Application Specialist
3M Health Care, Medical Solutions Division
St. Paul, Minnesota

Patricia Turner, BSN, RN, CWOCN, CWS
Director of Clinical Resources
Medline Industries, Inc.


Provided by North American Center for Continuing Medical Education, LLC (NACCME), an HMP Company.

For questions regarding this educational activity, please call 609-371-1137 or email


This activity is designed for physicians, nurse practitioners, physician assistants, nurses, physical therapists, and podiatrists involved in wound healing or wound care issues.


After participating in this activity, learners should be better able to:

  • Identify the pathophysiology of venous disease and phlebolymphedema
  • Explore clinical decision-making prior to implementing compression to manage edema across the spectrum
  • Examine the latest innovations in compression therapy

To be eligible for credit, participants must complete the online activity and the evaluation. Upon completing the activity, there will be instructions on how to complete the evaluation and print a certificate or other documentation of credit.

Release Date: November 20, 2020
Expiration Date: April 1, 2021
Estimated Time to Complete: 2.50 hours

There is no fee associated with this activity.


NACCME would like to thank the following companies who have supported "Advances in Compression Therapy for Venous and Lymphatic Disorders" through educational grants and/or in-kind support: 3M Health Care, Medical Solutions Division; AMERX Health Care Corporation; Medline Industries, Inc.; Milliken Healthcare; SIGVARIS INC; and URGO Medical. 



In support of improving patient care, NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


NACCME designates this internet enduring activity for a maximum of 2.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


This continuing nursing education activity awards 2.50 contact hours.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 2.50 contact hours. 


American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME.


NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 2.50 AAPA Category 1 credits. PAs should only claim credit commensurate with the extent of their participation.


NACCME is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. NACCME has approved this activity for a maximum of 2.50 continuing education contact hour.


This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.


This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of NACCME.


The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.

Neither NACCME nor any of its subsidiaries or affiliates is affiliated with, or formally endorsed by a medical society.

The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME or HMP. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.


NACCME, LLC is an independent provider(s) of continuing medical education. NACCME, LLC has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.

NACCME, LLC assures that all educational materials are reviewed to ensure for the absence of commercial bias, fair balance, scientific objectivity, and levels of evidence. The educational activity will not be influenced by commercial organizations and will not conflict with any other scheduled educational activities.

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

Clinical Reviewers

Daniel Federman, MD, FACP
Professor of Medicine
Yale University School of Medicine
Associate Chief of Medicine
VA Connecticut Healthcare System
West Haven, Connecticut

Nurse Planner: Susie Seaman, NP, MSN, CWOCN, Infectious Disease Consultants/San Diego Infusion Center, San Diego, CA

Planning Committee

In addition to the faculty listed below, NACCME planners and staff include Christopher Bolwell, Samantha Conforti, Marissa Grossman, Mary Johnson, Tiffney Oliver, Randy Robbin and Greaton Sellers. 

Christopher Bolwell is a shareholder of GlaxoSmithKline. GlaxoSmithKline is not supporting this activity, nor does any content relate to their products or services.

No other planner has disclosed a relevant financial relationship with any commercial interest.


The faculty has reported the following:

Emily Greenstein, APRN, CNP, CWON, FACCWS: Speakers’ Bureau–URGO Medical

Jeffrey D. Lehrman, DPM, FASPS, MAPWCA, CPC: Consultant – AMERX Healthcare

Gwen McComy, RN, BSN is an employee of Milliken Healthcare

Yvette Mier, BSN, RN, CWON: Clinical Consultant—SIGVARIS, Inc.

Lynn Peterson, RN, CWOCN, CLWT: Employee—3M Health Care, Medical Solutions Division

Stanley G. Rockson, MD: Chief Medical Officer, Koya, Inc.

Ms. Seaman: Speakers' Bureau—Next Science

Patricia Turner, BSN, RN, CWOCN, CWS: Employee—Medline Industries, Inc.

Dr. Federman and Mr. Repicci have disclosed no relevant financial relationship with any commercial interest.


North American Center for Continuing Medical Education (NACCME) complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.


NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint providers. NACCME and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2020 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.


Any participant wanting to file a grievance with respect to any aspect of a continuing education activity accredited by NACCME, LLC may contact Samantha Conforti, Manager, Accreditation and Compliance, by phone at 609-371-1137, by email at or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. The Manager, Accreditation and Compliance will review the grievance and respond within 30 days of receiving the complaint. If the participant is unsatisfied with the response, an appeal to the Senior Manager/Director or the Executive Vice President, Chris Bolwell, Accreditation and Compliance, can be requested for a second level of review. Mr. Bolwell can be contacted via phone at 678-242-0801, by email at or in writing at 11675 Rainwater Drive, Suite 600 Alpharetta, GA 30009.